Patent Law Weblog
recent posts
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
- United States Files Statement of Interest in Patent Infringement Proceedings
about
Month: December 2007
-
By Kevin E. Noonan — Keith Olbermann, former ESPN co-anchor of SportsCenter and for the past few years the host of MSNBC’s Countdown, has noted the correlation between bad political news for the Bush administration and heightening of terror threat warnings (see "The Nexus of Politics and Terror," Countdown, 10/12/2005). While not in…
-
By Christopher P. Singer — In a December 17, 2007 press release, Otsuka Pharmaceutical Co., Ltd. and PDL BioPharma, Inc. announced a finalized agreement in which Otsuka acquires intellectual property related assets to IV Busulfex® (busulfan) from PDL. Under the agreement, Otsuka obtains rights to trademarks, patents, and other Busulfex-related assets, in return…
-
By Kevin E. Noonan — Judge James C. Cacheris of the U.S. District Court for the Eastern District of Virginia today extended until December 27th the deadline for the parties to file summary judgment motions regarding the merits of plaintiffs’ complaint seeking a permanent injunction against implementation of the misguided "new rules" relating…
-
By Jason Derry — Affymetrix Inc. has announced today that it will acquire USB Corporation for approximately $75 million. USB develops and sells molecular biology products, biochemical reagents, and DNA sequencing reagents, including enzymes and kits for molecular biology research applications. Affymetrix is a leader in the field of microarray technology for genetic…
-
By Donald Zuhn — Last week, we received two messages from a reader (aka: "Patent Warrior") regarding an article published in China Intellectual Property News on November 7, 2007, and the response to this article by U.S. Representatives Michael Michaud (D-ME) and Donald Manzullo (R-IL). The article, which was only recently translated (a…
-
By Kevin E. Noonan — There is something about biotechnology that brings out the Cassandras (which is being kind; "Chicken Little" is a more accurate characterization) in people who oppose it. Whether motivated by a renewed "vitalism" (see "Science Fiction in The New York Times") or some kind of green (or Green) impulse,…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic monitoring. Monsanto Company et al. v. Gastel3:07-cv-05119; filed December 12, 2007 in the Western District of Missoui Infringement of U.S. Patent Nos. 5,352,605…
-
January 4-8, 2008 – 25th Annual National CLE Conference (law Education Institute, Inc.) – Vail, CO January 9, 2008 – Patent Claim Construction (Law Seminars International) – San Francisco, CA January 14-15, 2008 – Patent Law Institute (Practising Law Institute) – New York, NY January 25-26, 2008 – Buying, Selling and Licensing Patents: New Case…
-
By Robert Dailey — Life sciences companies Invitrogen and Genetic Applications (GA) have settled the patent infringement suit that GA filed last year alleging infringement of U.S. Reissued Patent No. RE39,220. The ‘220 patent is directed to methods of transplanting DNA into a eukaryotic genome to yield hematopoietic cell lines. These cell lines…
-
The Biotechnology Industry Organization (BIO) will be holding its annual BIO International Convention on June 17-20, 2008 in San Diego, CA. Founded in 1993, BIO is a nonprofit association seeking supportive biotechnology policies on behalf of more than 1,100 biotechnology companies, state and international affiliates, and related organizations, as well as providing business development services…
Patent Docs 